Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Current Nanomedicine
  4. Volume 15, Issue 1
  5. Article
Volume 15, Issue 1
  • ISSN: 2468-1873
  • E-ISSN: 2468-1881

Abstract

Background

Lipid-based formulations, such as Nanostructured lipid carriers (NLCs), have been thoroughly studied as drug delivery platforms. NLCs are binary systems composed of both solid and liquid lipids that aim to produce a lipidic core that is less ordered. Components of NLCs particularly influence the physicochemical characteristics and efficacy of the final product.

Morphology

They contain a solid matrix at room temperature and are thought to be superior to many other conventional lipids-based nanocarriers, such as solid lipid nanoparticles (SLNs), nanoemulsions, and liposomes because of their improved stability, drug loading capacity, good biocompatibility, enhanced permeability, bioavailability, extended half-life, fewer side effects, tissue-specific delivery and wide range of potential applications.

Significance

NLCs have multiple applications in the manufacturing of pharmaceuticals and cosmetics due to their ease of preparation, the feasibility of scale-up, non-toxic, improved targeting efficiency and potential for site-specific delivery various routes of administration.

Scope of Review

This review enlightens about the most recent developments of NLCs as a drug delivery system, types of NLCs, current techniques to prepare NLCs, and characterization techniques that are essential for the development of safe, effective and stable formulation. It also encompasses the potential of using NLCs for various administration routes and recent developments in pharmaceutical applications with successful outcomes.

Conclusion

This review certainly provide great insight into formulation considerations using design experts and modification strategies for improved targeting. On the whole, NLCs are broadly explored and preferred lipid nanocarrier systems with several advantages.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cnanom/10.2174/0124681873283751240206071835
2024-02-22
2024-12-25

  • From This Site

    /content/journals/cnanom/10.2174/0124681873283751240206071835
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. AlexisF. RheeJ.W. RichieJ.P. Radovic-MorenoA.F. LangerR. FarrokhzadO.C. New frontiers in nanotechnology for cancer treatment.Urologic Oncology: Seminars and Original Investigations 2008261748510.1016/j.urolonc.2007.03.017
     [Google Scholar]
  2. JaiswalP. GidwaniB. VyasA. Nanostructured lipid carriers and their current application in targeted drug delivery.Artif. Cells Nanomed. Biotechnol.2016441274010.3109/21691401.2014.90982224813223
     [Google Scholar]
  3. TapeinosC. BattagliniM. CiofaniG. Advances in the design of solid lipid nanoparticles and nanostructured lipid carriers for targeting brain diseases.J. Control. Release201726430633210.1016/j.jconrel.2017.08.03328844756
     [Google Scholar]
  4. AkbarzadehA. Rezaei-SadabadyR. DavaranS. JooS.W. ZarghamiN. HanifehpourY. SamieiM. KouhiM. Nejati-KoshkiK. Liposome: Classification, preparation, and applications.Nanoscale Res. Lett.20138110210.1186/1556‑276X‑8‑10223432972
     [Google Scholar]
  5. PuriA LoomisK SmithB LeeJH YavlovichA HeldmanE BlumenthalR Lipid-based nanoparticles as pharmaceutical drug carriers: From concepts to clinic.Critical Reviews™ in Therapeutic Drug Carrier Systems.200926352358010.1615/CritRevTherDrugCarrierSyst.v26.i6.10
     [Google Scholar]
  6. SatoY. NakamuraT. YamadaY. HarashimaH. The nanomedicine rush: New strategies for unmet medical needs based on innovative nano DDS.J. Control. Release202133030531610.1016/j.jconrel.2020.12.03233358975
     [Google Scholar]
  7. EissaN.G. ElsabahyM. AllamA. Engineering of smart nanoconstructs for delivery of glucagon-like peptide-1 analogs.Int. J. Pharm.202159712031710.1016/j.ijpharm.2021.12031733540005
     [Google Scholar]
  8. PardeikeJ. HommossA. MüllerR.H. Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products.Int. J. Pharm.20093661-217018410.1016/j.ijpharm.2008.10.00318992314
     [Google Scholar]
  9. SubramaniamB. SiddikZ.H. NagoorN.H. Optimization of nanostructured lipid carriers: Understanding the types, designs, and parameters in the process of formulations.J. Nanopart. Res.202022614110.1007/s11051‑020‑04848‑0
     [Google Scholar]
  10. Gordillo-GaleanoA. Mora-HuertasC.E. Solid lipid nanoparticles and nanostructured lipid carriers: A review emphasizing on particle structure and drug release.Eur. J. Pharm. Biopharm.201813328530810.1016/j.ejpb.2018.10.01730463794
     [Google Scholar]
  11. GarcêsA. AmaralM.H. Sousa LoboJ.M. SilvaA.C. Formulations based on solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for cutaneous use: A review.Eur. J. Pharm. Sci.201811215916710.1016/j.ejps.2017.11.02329183800
     [Google Scholar]
  12. MehnertW. MäderK. Solid lipid nanoparticles.Adv. Drug Deliv. Rev.2012648310110.1016/j.addr.2012.09.02111311991
     [Google Scholar]
  13. MullerRH RadtkeM WissingSA Solid lipid nanoparticles and nanostructured lipid carriersEncyclopaedia of nanoscience and nanotechnology American Scientific Publishers20049564356
     [Google Scholar]
  14. HajareA.A. MaliS.S. AhirA.A. ThoratJ.D. SalunkheS.S. NadafS.J. BhatiaN.M. ChitranagariK. Lipid nanoparticles: A modern formulation approach in topical drug delivery systems.J. Adv. Drug Deliv.2014113037
     [Google Scholar]
  15. ElzenyH. ZhangF. AliE. FathiH. ZhangS. LiR. El-MokhtarM.A. HamadM.A. WooleyK. ElsabahyM. Polyphosphoester nanoparticles as biodegradable platform for delivery of multiple drugs and siRNA.Drug Des. Devel. Ther.20171148349610.2147/DDDT.S12850328260861
     [Google Scholar]
  16. ZhangF. KhanS. LiR. SmolenJ.A. ZhangS. ZhuG. SuL. JahnkeA.A. ElsabahyM. ChenX. WooleyK.L. Design and development of multifunctional polyphosphoester-based nanoparticles for ultrahigh paclitaxel dual loading.Nanoscale2017941157731577710.1039/C7NR05935C29034932
     [Google Scholar]
  17. DoktorovovaS. SoutoE.B. SilvaA.M. Nanotoxicology applied to solid lipid nanoparticles and nanostructured lipid carriers – A systematic review of in vitro data.Eur. J. Pharm. Biopharm.201487111810.1016/j.ejpb.2014.02.00524530885
     [Google Scholar]
  18. ZsikóS. CutcherK. KovácsA. Budai-SzűcsM. GácsiA. BakiG. CsányiE. BerkóS. Nanostructured lipid carrier gel for the dermal application of lidocaine: Comparison of skin penetration testing methods.Pharmaceutics201911731010.3390/pharmaceutics1107031031269690
     [Google Scholar]
  19. NaseriN. ValizadehH. Zakeri-MilaniP. Solid lipid nanoparticles and nanostructured lipid carriers: Structure, preparation and application.Adv. Pharm. Bull.20155330531310.15171/apb.2015.04326504751
     [Google Scholar]
  20. LiF. WangY. LiuZ. LinX. HeH. TangX. Formulation and characterization of bufadienolides-loaded nanostructured lipid carriers.Drug Dev. Ind. Pharm.201036550851710.3109/0363904090326439719821716
     [Google Scholar]
  21. PardeikeJ. WeberS. HaberT. WagnerJ. ZarflH.P. PlankH. ZimmerA. Development of an Itraconazole-loaded nanostructured lipid carrier (NLC) formulation for pulmonary application.Int. J. Pharm.20114191-232933810.1016/j.ijpharm.2011.07.04021839157
     [Google Scholar]
  22. SharmaA. BaldiA. Nanostructured lipid carriers: A review.J. Dev. Drugs20187215
     [Google Scholar]
  23. HaiderM. AbdinS.M. KamalL. OriveG. Nanostructured lipid carriers for delivery of chemotherapeutics: A review.Pharmaceutics202012328810.3390/pharmaceutics1203028832210127
     [Google Scholar]
  24. Czajkowska-KośnikA. SzekalskaM. WinnickaK. Nanostructured lipid carriers: A potential use for skin drug delivery systems.Pharmacol. Rep.201971115616610.1016/j.pharep.2018.10.00830550996
     [Google Scholar]
  25. PurohitDK Nano-lipid carriers for topical application: Current scenario.Asian J. Pharm.2016101
     [Google Scholar]
  26. PatnaikS. PurohitD. BiswasroyP. DiabW.M. DubeyA. Recent advances for commedonal acne treatment by employing lipid nanocarriers topically.Int. J. Health Sci.20226180205
     [Google Scholar]
  27. VijayanV. AafreenS. SakthivelS. ReddyK.R. Formulation and characterization of solid lipid nanoparticles loaded Neem oil for topical treatment of acne.J. Acute Dis.20132428228610.1016/S2221‑6189(13)60144‑4
     [Google Scholar]
  28. SalvankarS.S. AghavA.A. MahaleD.S. KshirsagarS.S. RatnaparkhiM.P. Nanostructured lipid carriers: The advanced lipid carriers and their applications.Int. J. Pharm. Sci. Res.202314254756110.13040/IJPSR.0975‑8232.14(2).547‑61
     [Google Scholar]
  29. ShidhayeS. VaidyaR. SutarS. PatwardhanA. KadamV. Solid lipid nanoparticles and nanostructured lipid carriers--innovative generations of solid lipid carriers.Curr. Drug Deliv.20085432433110.2174/15672010878591508718855604
     [Google Scholar]
  30. PatelD.K. TripathyS. NairS.K. KesharwaniR. Nanostructured lipid carrier (NLC) a modern approach for topical delivery: A review.World J. Pharm. Pharm. Sci.201323921938
     [Google Scholar]
  31. SalviV.R. PawarP. Nanostructured lipid carriers (NLC) system: A novel drug targeting carrier.J. Drug Deliv. Sci. Technol.20195125526710.1016/j.jddst.2019.02.017
     [Google Scholar]
  32. MahantS. RaoR. NandaS. Nanostructured lipid carriers: Revolutionizing skin care and topical therapeutics.Design of nanostructures for versatile therapeutic applications.William Andrew Publishing20189713610.1016/B978‑0‑12‑813667‑6.00003‑6
     [Google Scholar]
  33. DasS. ChaudhuryA. Recent advances in lipid nanoparticle formulations with solid matrix for oral drug delivery.AAPS PharmSciTech2011121627610.1208/s12249‑010‑9563‑021174180
     [Google Scholar]
  34. BettsJ.N. JohnsonM.G. RygiewiczP.T. KingG.A. AndersenC.P. Potential for metal contamination by direct sonication of nanoparticle suspensions.Environ. Toxicol. Chem.201332488989310.1002/etc.212323322586
     [Google Scholar]
  35. GomaaE. FathiH.A. EissaN.G. ElsabahyM. Methods for preparation of nanostructured lipid carriers.Methods20221993810.1016/j.ymeth.2021.05.00333992771
     [Google Scholar]
  36. ShahgaldianP. Da SilvaE. ColemanA.W. RatherB. ZaworotkoM.J. Para-acyl-calix-arene based solid lipid nanoparticles (SLNs): A detailed study of preparation and stability parameters.Int. J. Pharm.20032531-2233810.1016/S0378‑5173(02)00639‑712593934
     [Google Scholar]
  37. KaurS NautyalU SinghR SinghS DeviA. Nanostructure lipid carrier (NLC): The new generation of lipid nanoparticles.Asian Pac. J. Health Sci.2005227693
     [Google Scholar]
  38. DateA. JoshiM. PatravaleV. Parasitic diseases: Liposomes and polymeric nanoparticles versus lipid nanoparticles.Adv. Drug Deliv. Rev.200759650552110.1016/j.addr.2007.04.00917574295
     [Google Scholar]
  39. BattagliaL GallarateM PancianiPP UgazioE SapinoS PeiraE Techniques for the preparation of solid lipid nano and microparticles.Application of Nanotechnology in Drug Delivery201410.5772/58405
     [Google Scholar]
  40. RathodV.R. ShahD.A. DaveR.H. Systematic implementation of quality-by-design (QbD) to develop NSAID-loaded nanostructured lipid carriers for ocular application: preformulation screening studies and statistical hybrid-design for optimization of variables.Drug Dev. Ind. Pharm.202046344345510.1080/03639045.2020.172413532037896
     [Google Scholar]
  41. GadagS. NarayanR. NayakA.S. Catalina ArdilaD. SantS. NayakY. GargS. NayakU.Y. Development and preclinical evaluation of microneedle-assisted resveratrol loaded nanostructured lipid carriers for localized delivery to breast cancer therapy.Int. J. Pharm.202160612087710.1016/j.ijpharm.2021.12087734252522
     [Google Scholar]
  42. AlamT. KhanS. GabaB. HaiderM.F. BabootaS. AliJ. Adaptation of quality by design-based development of isradipine nanostructured–lipid carrier and its evaluation for in vitro gut permeation and in vivo solubilization fate.J. Pharm. Sci.2018107112914292610.1016/j.xphs.2018.07.02130076853
     [Google Scholar]
  43. RangarajN. PaillaS.R. ShahS. PrajapatiS. SampathiS. QbD aided development of ibrutinib-loaded nanostructured lipid carriers aimed for lymphatic targeting: Evaluation using chylomicron flow blocking approach.Drug Deliv. Transl. Res.20201051476149410.1007/s13346‑020‑00803‑732519202
     [Google Scholar]
  44. TavakoliN. TaymouriS. SaeidiA. AkbariV. Thermosensitive hydrogel containing sertaconazole loaded nanostructured lipid carriers for potential treatment of fungal keratitis.Pharm. Dev. Technol.201924789190110.1080/10837450.2019.161675531062987
     [Google Scholar]
  45. Czajkowska-KośnikA. SzymańskaE. CzarnomysyR. JacynaJ. MarkuszewskiM. BasaA. WinnickaK. Nanostructured lipid carriers engineered as topical delivery of etodolac: Optimization and cytotoxicity studies.Materials202114359610.3390/ma1403059633514018
     [Google Scholar]
  46. PokharkarV. Patil-GadheA. PallaP. Efavirenz loaded nanostructured lipid carrier engineered for brain targeting through intranasal route: in-vivo pharmacokinetic and toxicity study.Biomed. Pharmacother.20179415016410.1016/j.biopha.2017.07.06728759752
     [Google Scholar]
  47. AgrawalY. PetkarK.C. SawantK.K. Development, evaluation and clinical studies of Acitretin loaded nanostructured lipid carriers for topical treatment of psoriasis.Int. J. Pharm.20104011-29310210.1016/j.ijpharm.2010.09.00720858539
     [Google Scholar]
  48. HassanD.H. ShohdyJ.N. El-SetouhyD.A. El-NabarawiM. NaguibM.J. Compritol-based nanostructured lipid carriers (NLCs) for augmentation of zolmitriptan bioavailability via the transdermal route: in vitro optimization, ex-vivo permeation, in vivo pharmacokinetic study.Pharmaceutics2022147148410.3390/pharmaceutics1407148435890379
     [Google Scholar]
  49. PatelH.P. GandhiP.A. ChaudhariP.S. DesaiB.V. DesaiD.T. DedhiyaP.P. MaulviF.A. VyasB.A. Clozapine loaded nanostructured lipid carriers engineered for brain targeting via nose-to-brain delivery: Optimization and in vivo pharmacokinetic studies.J. Drug Deliv. Sci. Technol.20216410253310.1016/j.jddst.2021.102533
     [Google Scholar]
  50. SwidanSA MansourZN MouradZA ElhesaisyNA MohamedNA BekheetMS BadawyMA ElsemeiriMM ElrefaeyAE HassaneenAM DOE, formulation, and optimization of Repaglinide nanostructured lipid carriers.J. Appl. Pharm. Sci.2018810816
     [Google Scholar]
  51. ZhangX. LiuJ. QiaoH. LiuH. NiJ. ZhangW. ShiY. Formulation optimization of dihydroartemisinin nanostructured lipid carrier using response surface methodology.Powder Technol.20101971-212012810.1016/j.powtec.2009.09.004
     [Google Scholar]
  52. LuoQ. YangJ. XuH. ShiJ. LiangZ. ZhangR. LuP. PuG. ZhaoN. ZhangJ. Sorafenib-loaded nanostructured lipid carriers for topical ocular therapy of corneal neovascularization: Development, in-vitro and in vivo study.Drug Deliv.202229183785510.1080/10717544.2022.204813435277107
     [Google Scholar]
  53. HejriA. KhosraviA. GharanjigK. HejaziM. Optimisation of the formulation of β-carotene loaded nanostructured lipid carriers prepared by solvent diffusion method.Food Chem.2013141111712310.1016/j.foodchem.2013.02.08023768336
     [Google Scholar]
  54. TamjidiF. ShahediM. VarshosazJ. NasirpourA. Design and characterization of astaxanthin-loaded nanostructured lipid carriers.Innov. Food Sci. Emerg. Technol.20142636637410.1016/j.ifset.2014.06.012
     [Google Scholar]
  55. AgrawalM. SarafS. PradhanM. PatelR.J. SinghviG. Ajazuddin AlexanderA. Design and optimization of curcumin loaded nano lipid carrier system using Box-Behnken design.Biomed. Pharmacother.202114111191910.1016/j.biopha.2021.11191934328108
     [Google Scholar]
  56. PradhanM. SinghD. SinghM.R. Fabrication, optimization and characterization of Triamcinolone acetonide loaded nanostructured lipid carriers for topical treatment of psoriasis: Application of Box Behnken design, in vitro and ex-vivo studies.J. Drug Deliv. Sci. Technol.20174132533310.1016/j.jddst.2017.07.024
     [Google Scholar]
  57. MaY. LiuJ. CuiX. HouJ. YuF. WangJ. WangX. ChenC. TongL. Hyaluronic acid modified nanostructured lipid carrier for targeting delivery of kaempferol to NSCLC: Preparation, optimization, characterization, and performance evaluation in vitro.Molecules20222714455310.3390/molecules2714455335889427
     [Google Scholar]
  58. AmeeduzzafarQ.M. QumberM. AlruwailiN.K. BukhariS.N.A. AlharbiK.S. ImamS.S. AfzalM. AlsuwaytB. MujtabaA. AliA. BBD-based development of itraconazole loaded nanostructured lipid carrier for topical delivery: in vitro evaluation and antimicrobial assessment.J. Pharm. Innov.2021161859810.1007/s12247‑019‑09420‑5
     [Google Scholar]
  59. MahmoodA. RapalliV.K. GorantlaS. WaghuleT. SinghviG. Dermatokinetic assessment of luliconazole-loaded nanostructured lipid carriers (NLCs) for topical delivery: QbD-driven design, optimization, and in vitro and ex-vivo evaluations.Drug Deliv. Transl. Res.20221251118113510.1007/s13346‑021‑00986‑733895936
     [Google Scholar]
  60. GabaB. FazilM. KhanS. AliA. BabootaS. AliJ. Nanostructured lipid carrier system for topical delivery of terbinafine hydrochloride.Bull. Fac. Pharm. Cairo Univ.201553214715910.1016/j.bfopcu.2015.10.001
     [Google Scholar]
  61. PereiraR.R. TestiM. RossiF. Silva JuniorJ.O.C. Ribeiro-CostaR.M. BettiniR. SantiP. PadulaC. SonvicoF. Ucuùba (Virola surinamensis) fat-based nanostructured lipid carriers for nail drug delivery of ketoconazole: Development and optimization using box-Behnken design.Pharmaceutics201911628410.3390/pharmaceutics1106028431212993
     [Google Scholar]
  62. KraisitP. SarisutaN. Development of triamcinolone acetonide-loaded nanostructured lipid carriers (NLCs) for buccal drug delivery using the Box-Behnken design.Molecules201823498210.3390/molecules2304098229690622
     [Google Scholar]
  63. KangQ. LiuJ. LiuX.Y. MoN.L. WangY.J. ZhaoY. LiuX. WuQ. Application of quality by design approach to formulate and optimize tripterine loaded in nanostructured lipid carriers for transdermal delivery.J. Drug Deliv. Sci. Technol.2019521032104110.1016/j.jddst.2019.06.006
     [Google Scholar]
  64. JazuliI. Annu NabiB. moolakkadathT. AlamT. BabootaS. AliJ. Optimization of nanostructured lipid carriers of lurasidone hydrochloride using Box-Behnken design for brain targeting: in vitro and in vivo studies.J. Pharm. Sci.201910893082309010.1016/j.xphs.2019.05.00131077685
     [Google Scholar]
  65. EmamiJ. RezazadehM. SadeghiH. KhadivarK. Development and optimization of transferrin-conjugated nanostructured lipid carriers for brain delivery of paclitaxel using Box–Behnken design.Pharm. Dev. Technol.201722337038210.1080/10837450.2016.118993327689412
     [Google Scholar]
  66. MathurP. SharmaS. RawalS. PatelB. PatelM.M. Fabrication, optimization, and in vitro evaluation of docetaxel-loaded nanostructured lipid carriers for improved anticancer activity.J. Liposome Res.202030218219610.1080/08982104.2019.161405531060404
     [Google Scholar]
  67. ChaudharyS. GargT. MurthyR.S.R. RathG. GoyalA.K. Development, optimization and evaluation of long chain nanolipid carrier for hepatic delivery of silymarin through lymphatic transport pathway.Int. J. Pharm.20154851-210812110.1016/j.ijpharm.2015.02.07025735668
     [Google Scholar]
  68. GilaniS.J. Bin-JumahM. RizwanullahM. ImamS.S. ImtiyazK. AlshehriS. RizviM.M.A. Chitosan coated luteolin nanostructured lipid carriers: Optimization, in vitro-ex-vivo assessments and cytotoxicity study in breast cancer cells.Coatings202111215810.3390/coatings11020158
     [Google Scholar]
  69. PyoY.C. TranP. KimD.H. ParkJ.S. Chitosan-coated nanostructured lipid carriers of fenofibrate with enhanced oral bioavailability and efficacy.Colloids Surf. B Biointerfaces202019611133110.1016/j.colsurfb.2020.11133132906001
     [Google Scholar]
  70. ChenY. FengX. ZhaoY. ZhaoX. ZhangX. Mussel-inspired polydopamine coating enhances the intracutaneous drug delivery from nanostructured lipid carriers dependently on a follicular pathway.Mol. Pharm.20201741215122510.1021/acs.molpharmaceut.9b0124032167771
     [Google Scholar]
  71. PaiR.V. VaviaP.R. Chitosan oligosaccharide enhances binding of nanostructured lipid carriers to ocular mucins: Effect on ocular disposition.Int. J. Pharm.202057711909510.1016/j.ijpharm.2020.11909532004680
     [Google Scholar]
  72. EidR.K. AshourD.S. EssaE.A. El MaghrabyG.M. ArafaM.F. Chitosan coated nanostructured lipid carriers for enhanced in vivo efficacy of albendazole against Trichinella spiralis.Carbohydr. Polym.202023211582610.1016/j.carbpol.2019.11582631952620
     [Google Scholar]
  73. ZewailM. NafeeN. HelmyM.W. BoraieN. Coated nanostructured lipid carriers targeting the joints – An effective and safe approach for the oral management of rheumatoid arthritis.Int. J. Pharm.201956711844710.1016/j.ijpharm.2019.11844731226475
     [Google Scholar]
  74. BashiriS. GhanbarzadehB. AyasehA. DehghannyaJ. EhsaniA. Preparation and characterization of chitosan-coated nanostructured lipid carriers (CH-NLC) containing cinnamon essential oil for enriching milk and anti-oxidant activity.Lebensm. Wiss. Technol.202011910883610.1016/j.lwt.2019.108836
     [Google Scholar]
  75. BangK.H. NaY.G. HuhH.W. HwangS.J. KimM.S. KimM. LeeH.K. ChoC.W. The delivery strategy of paclitaxel nanostructured lipid carrier coated with platelet membrane.Cancers201911680710.3390/cancers1106080731212681
     [Google Scholar]
  76. Malgarim CordenonsiL. FaccendiniA. CatanzaroM. BonferoniM.C. RossiS. MalavasiL. Platcheck RaffinR. Scherman SchapovalE.E. LanniC. SandriG. FerrariF. The role of chitosan as coating material for nanostructured lipid carriers for skin delivery of fucoxanthin.Int. J. Pharm.201956711848710.1016/j.ijpharm.2019.11848731271813
     [Google Scholar]
  77. Ling TanJ.S. RobertsC.J. BillaN. Mucoadhesive chitosan-coated nanostructured lipid carriers for oral delivery of amphotericin B.Pharm. Dev. Technol.201924450451210.1080/10837450.2018.151522530132723
     [Google Scholar]
  78. RabeloR.S. OliveiraI.F. da SilvaV.M. PrataA.S. HubingerM.D. Chitosan coated nanostructured lipid carriers (NLCs) for loading Vitamin D: A physical stability study.Int. J. Biol. Macromol.201811990291210.1016/j.ijbiomac.2018.07.17430063935
     [Google Scholar]
  79. NoorN.M. SheikhK. SomavarapuS. TaylorK.M.G. Preparation and characterization of dutasteride-loaded nanostructured lipid carriers coated with stearic acid-chitosan oligomer for topical delivery.Eur. J. Pharm. Biopharm.201711737238410.1016/j.ejpb.2017.04.01228412472
     [Google Scholar]
  80. GaoX. ZhangJ. XuQ. HuangZ. WangY. ShenQ. Hyaluronic acid-coated cationic nanostructured lipid carriers for oral vincristine sulfate delivery.Drug Dev. Ind. Pharm.201743466166710.1080/03639045.2016.127567128043185
     [Google Scholar]
  81. YinJ. HouY. YinY. SongX. Selenium-coated nanostructured lipid carriers used for oral delivery of berberine to accomplish a synergic hypoglycemic effect.Int. J. Nanomedicine2017128671868010.2147/IJN.S14461529263662
     [Google Scholar]
  82. GartziandiaO. HerranE. PedrazJ.L. CarroE. IgartuaM. HernandezR.M. Chitosan coated nanostructured lipid carriers for brain delivery of proteins by intranasal administration.Colloids Surf. B Biointerfaces201513430431310.1016/j.colsurfb.2015.06.05426209963
     [Google Scholar]
  83. ZhangW. LiX. YeT. ChenF. YuS. ChenJ. YangX. YangN. ZhangJ. LiuJ. PanW. KongJ. Nanostructured lipid carrier surface modified with Eudragit RS 100 and its potential ophthalmic functions.Int. J. Nanomedicine201494305431525246787
     [Google Scholar]
  84. BeloquiA. SolinísM.Á. RieuxA. PréatV. Rodríguez-GascónA. Dextran–protamine coated nanostructured lipid carriers as mucus-penetrating nanoparticles for lipophilic drugs.Int. J. Pharm.20144681-210511110.1016/j.ijpharm.2014.04.02724746410
     [Google Scholar]
  85. YangX. LiY. LiM. ZhangL. FengL. ZhangN. Hyaluronic acid-coated nanostructured lipid carriers for targeting paclitaxel to cancer.Cancer Lett.2013334233834510.1016/j.canlet.2012.07.00222776563
     [Google Scholar]
  86. ChenY. YuanL. ZhouL. ZhangZ.H. CaoW. WuQ. Effect of cell-penetrating peptide-coated nanostructured lipid carriers on the oral absorption of tripterine.Int. J. Nanomedicine201274581459122942642
     [Google Scholar]
  87. KhajaviniaA. VarshosazJ. DehkordiA.J. Targeting etoposide to acute myelogenous leukaemia cells using nanostructured lipid carriers coated with transferrin.Nanotechnology2012234040510110.1088/0957‑4484/23/40/40510122983592
     [Google Scholar]
  88. LuoQ. ZhaoJ. ZhangX. PanW. Nanostructured lipid carrier (NLC) coated with Chitosan Oligosaccharides and its potential use in ocular drug delivery system.Int. J. Pharm.20114031-218519110.1016/j.ijpharm.2010.10.01320951778
     [Google Scholar]
  89. FangC.L. Al-SuwayehS.A. FangJ.Y. Nanostructured lipid carriers (NLCs) for drug delivery and targeting.Recent Pat. Nanotechnol.201371415510.2174/18722101380448482722946628
     [Google Scholar]
  90. MukherjeeS. RayS. ThakurR.S. Solid lipid nanoparticles: A modern formulation approach in drug delivery system.Indian J. Pharm. Sci.200971434935810.4103/0250‑474X.5728220502539
     [Google Scholar]
  91. JoresK. MehnertW. DrechslerM. BunjesH. JohannC. MäderK. Investigations on the structure of solid lipid nanoparticles (SLN) and oil-loaded solid lipid nanoparticles by photon correlation spectroscopy, field-flow fractionation and transmission electron microscopy.J. Control. Release200495221722710.1016/j.jconrel.2003.11.01214980770
     [Google Scholar]
  92. IqbalM.A. MdS. SahniJ.K. BabootaS. DangS. AliJ. Nanostructured lipid carriers system: Recent advances in drug delivery.J. Drug Target.2012201081383010.3109/1061186X.2012.71684522931500
     [Google Scholar]
  93. SvilenovH. TzachevC. Solid lipid nanoparticles–apromising drug delivery system.Nanomedicine20148188237
     [Google Scholar]
  94. WuM. FanY. LvS. XiaoB. YeM. ZhuX. Vincristine and temozolomide combined chemotherapy for the treatment of glioma: A comparison of solid lipid nanoparticles and nanostructured lipid carriers for dual drugs delivery.Drug Deliv.20162382720272510.3109/10717544.2015.105843426203691
     [Google Scholar]
  95. TamjidiF. ShahediM. VarshosazJ. NasirpourA. Nanostructured lipid carriers (NLC): A potential delivery system for bioactive food molecules.Innov. Food Sci. Emerg. Technol.201319294310.1016/j.ifset.2013.03.002
     [Google Scholar]
  96. MahantS. RaoR. SoutoE.B. NandaS. Analytical tools and evaluation strategies for nanostructured lipid carrier-based topical delivery systems.Expert Opin. Drug Deliv.202017796399210.1080/17425247.2020.177275032441158
     [Google Scholar]
  97. TichotaD.M. SilvaA.C. Sousa LoboJ.M. AmaralM.H. Design, characterization, and clinical evaluation of argan oil nanostructured lipid carriers to improve skin hydration.Int. J. Nanomedicine201493855386425143733
     [Google Scholar]
  98. UpritS. Kumar SahuR. RoyA. PareA. Preparation and characterization of minoxidil loaded nanostructured lipid carrier gel for effective treatment of alopecia.Saudi Pharm. J.201321437938510.1016/j.jsps.2012.11.00524227958
     [Google Scholar]
  99. SoutoE.B. MüllerR.H. Challenging cosmetics: Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC). Science and Applications of Skin Delivery Systems.Chapter 13 WiechersJ. KozlowskiA.
    [Google Scholar]
  100. ÜnerM. Characterization and imaging of solid lipid nanoparticles and nanostructured lipid carriers.Handbook of nanoparticles.ChamSpringer201611714110.1007/978‑3‑319‑15338‑4_3
     [Google Scholar]
  101. RahmanH. RasedeeA. HowC.W. AbdulA.B. AllaudinZ.N. OthmanH. SaeedM. YeapS. Zerumbone-loaded nanostructured lipid carriers: Preparation, characterization, and antileukemic effect.Int. J. Nanomedicine201382769278110.2147/IJN.S4531323946649
     [Google Scholar]
  102. YoonG. ParkJ.W. YoonI.S. Solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs): Recent advances in drug delivery.J. Pharm. Investig.201343535336210.1007/s40005‑013‑0087‑y
     [Google Scholar]
  103. KhosaA. ReddiS. SahaR.N. Nanostructured lipid carriers for site-specific drug delivery.Biomed. Pharmacother.201810359861310.1016/j.biopha.2018.04.05529677547
     [Google Scholar]
  104. BunjesH. UnruhT. Characterization of lipid nanoparticles by differential scanning calorimetry, X-ray and neutron scattering.Adv. Drug Deliv. Rev.200759637940210.1016/j.addr.2007.04.01317658653
     [Google Scholar]
  105. MoghimiS.M. HunterA.C. AndresenT.L. Factors controlling nanoparticle pharmacokinetics: An integrated analysis and perspective.Annu. Rev. Pharmacol. Toxicol.201252148150310.1146/annurev‑pharmtox‑010611‑13462322035254
     [Google Scholar]
  106. SahanaB. SantraK. BasuS. MukherjeeB. Development of biodegradable polymer based tamoxifen citrate loaded nanoparticles and effect of some manufacturing process parameters on them: A physicochemical and in-vitro evaluation.Int. J. Nanomedicine2010562163020856837
     [Google Scholar]
  107. DasS. NgW.K. TanR.B.H. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): Development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?Eur. J. Pharm. Sci.201247113915110.1016/j.ejps.2012.05.01022664358
     [Google Scholar]
  108. SantosS. NevesA.R. SilvaA. BarbosaM. ReisS. BarbosaJ. Nanostructured lipid carriers loaded with resveratrol modulate human dendritic cells.Int. J. Nanomedicine2016113501351610.2147/IJN.S10869427555771
     [Google Scholar]
  109. BeloquiA. SolinísM.Á. Rodríguez-GascónA. AlmeidaA.J. PréatV. Nanostructured lipid carriers: Promising drug delivery systems for future clinics.Nanomedicine201612114316110.1016/j.nano.2015.09.00426410277
     [Google Scholar]
  110. SoniN.K. SonaliL.J. SinghA. ManglaB. NeupaneY.R. KohliK. Nanostructured lipid carrier potentiated oral delivery of raloxifene for breast cancer treatment.Nanotechnology2020314747510110.1088/1361‑6528/abaf8132886644
     [Google Scholar]
  111. LiuD. LiuF. LiuZ. WangL. ZhangN. Tumor specific delivery and therapy by double-targeted nanostructured lipid carriers with anti-VEGFR-2 antibody.Mol. Pharm.2011862291230110.1021/mp200402e21923159
     [Google Scholar]
  112. KhuranaS. UtrejaP. TiwaryA.K. JainN.K. JainS. Nanostructured lipid carriers and their application in drug delivery.Int. J. Biomed. Eng. Technol.20092215217110.1504/IJBET.2009.022913
     [Google Scholar]
  113. JainS. JainP. UmamaheshwariR.B. JainN.K. Transfersomes--a novel vesicular carrier for enhanced transdermal delivery: Development, characterization, and performance evaluation.Drug Dev. Ind. Pharm.20032991013102610.1081/DDC‑12002545814606665
     [Google Scholar]
  114. ShailendraS. Salvankar AkshadaA. Aghav Devang S. Mahale Shital S. Kshirsagar Mukesh P. Ratnaparkhi Ratnaparkhi nanostructured lipid carriers: the advanced lipid carriers and their application.Int. J. Pharm. Sci. Res.2023142547561
     [Google Scholar]
  115. MüllerR.H. ShegokarR. KeckC.M. 20 years of lipid nanoparticles (SLN and NLC): Present state of development and industrial applications.Curr. Drug Discov. Technol.20118320722710.2174/15701631179679906221291409
     [Google Scholar]
  116. PradhanM. SinghD. MurthyS.N. SinghM.R. Design, characterization and skin permeating potential of Fluocinolone acetonide loaded nanostructured lipid carriers for topical treatment of psoriasis.Steroids2015101566310.1016/j.steroids.2015.05.01226049018
     [Google Scholar]
  117. WaghuleT. RapalliV.K. SinghviG. ManchandaP. HansN. DubeyS.K. HasnainM.S. NayakA.K. Voriconazole loaded nanostructured lipid carriers based topical delivery system: QbD based designing, characterization, in-vitro and ex-vivo evaluation.J. Drug Deliv. Sci. Technol.20195230331510.1016/j.jddst.2019.04.026
     [Google Scholar]
  118. SanadR.A. AbdelMalakN.S. elBayoomyT.S. BadawiA.A. Formulation of a novel oxybenzone-loaded nanostructured lipid carriers (NLCs).AAPS PharmSciTech20101141684169410.1208/s12249‑010‑9553‑221107771
     [Google Scholar]
  119. ZhuangC.Y. LiN. WangM. ZhangX.N. PanW.S. PengJ.J. PanY.S. TangX. Preparation and characterization of vinpocetine loaded nanostructured lipid carriers (NLC) for improved oral bioavailability.Int. J. Pharm.20103941-217918510.1016/j.ijpharm.2010.05.00520471464
     [Google Scholar]
  120. ElmowafyM. Al-SaneaM.M. Nanostructured lipid carriers (NLCs) as drug delivery platform: Advances in formulation and delivery strategies.Saudi Pharm. J.2021299999101210.1016/j.jsps.2021.07.01534588846
     [Google Scholar]
  121. RadtkeM. SoutoE.B. MüllerR.H. Nanostructured lipid carriers: A novel generation of solid lipid drug carriers.Pharma Technology Europe.2005744550
     [Google Scholar]
  122. FathiH.A. AllamA. ElsabahyM. FetihG. El-BadryM. Nanostructured lipid carriers for improved oral delivery and prolonged antihyperlipidemic effect of simvastatin.Colloids Surf. B Biointerfaces201816216223624510.1016/j.colsurfb.2017.11.06429197789
     [Google Scholar]
  123. VelmuruganR. SelvamuthukumarS. Development and optimization of ifosfamide nanostructured lipid carriers for oral delivery using response surface methodology.Appl. Nanosci.20166215917310.1007/s13204‑015‑0434‑6
     [Google Scholar]
  124. ElmowafyM. IbrahimH.M. AhmedM.A. ShalabyK. SalamaA. HefeshaH. Atorvastatin-loaded nanostructured lipid carriers (NLCs): Strategy to overcome oral delivery drawbacks.Drug Deliv.201724193294110.1080/10717544.2017.133782328617150
     [Google Scholar]
  125. TyagiP. SubramonyJ.A. Nanotherapeutics in oral and parenteral drug delivery: Key learnings and future outlooks as we think small.J. Control. Release201827215916810.1016/j.jconrel.2018.01.00929355619
     [Google Scholar]
  126. JiaL. ZhangD. LiZ. DuanC. WangY. FengF. WangF. LiuY. ZhangQ. Nanostructured lipid carriers for parenteral delivery of silybin: Biodistribution and pharmacokinetic studies.Colloids Surf. B Biointerfaces201080221321810.1016/j.colsurfb.2010.06.00820621458
     [Google Scholar]
  127. Sánchez-LópezE. EspinaM. DoktorovovaS. SoutoE.B. GarcíaM.L. Lipid nanoparticles (SLN, NLC): Overcoming the anatomical and physiological barriers of the eye – Part I – Barriers and determining factors in ocular delivery.Eur. J. Pharm. Biopharm.2017110707510.1016/j.ejpb.2016.10.00927789358
     [Google Scholar]
  128. DieboldY. CalongeM. Applications of nanoparticles in ophthalmology.Prog. Retin. Eye Res.201029659660910.1016/j.preteyeres.2010.08.00220826225
     [Google Scholar]
  129. GanL. WangJ. JiangM. BartlettH. OuyangD. EperjesiF. LiuJ. GanY. Recent advances in topical ophthalmic drug delivery with lipid-based nanocarriers.Drug Discov. Today2013185-629029710.1016/j.drudis.2012.10.00523092895
     [Google Scholar]
  130. SoutoE.B. DoktorovovaS. Gonzalez-MiraE. EgeaM.A. GarciaM.L. Feasibility of lipid nanoparticles for ocular delivery of anti-inflammatory drugs.Curr. Eye Res.201035753755210.3109/0271368100376016820597640
     [Google Scholar]
  131. BaigM.S. OwidaH. NjorogeW. SiddiquiA-R. YangY. Development and evaluation of cationic nanostructured lipid carriers for ophthalmic drug delivery of besifloxacin.J. Drug Deliv. Sci. Technol.20205510149610.1016/j.jddst.2019.101496
     [Google Scholar]
  132. YoussefA. DudhipalaN. MajumdarS. Ciprofloxacin loaded nanostructured lipid carriers incorporated into in-situ gels to improve management of bacterial endophthalmitis.Pharmaceutics202012657210.3390/pharmaceutics1206057232575524
     [Google Scholar]
  133. GastaldiL. BattagliaL. PeiraE. ChirioD. MuntoniE. SolazziI. GallarateM. DosioF. Solid lipid nanoparticles as vehicles of drugs to the brain: Current state of the art.Eur. J. Pharm. Biopharm.201487343344410.1016/j.ejpb.2014.05.00424833004
     [Google Scholar]
  134. KreuterJ. Drug delivery to the central nervous system by polymeric nanoparticles: What do we know?Adv. Drug Deliv. Rev.20147121410.1016/j.addr.2013.08.00823981489
     [Google Scholar]
  135. QiS. MarchaudD. CraigD.Q.M. An investigation into the mechanism of dissolution rate enhancement of poorly water-soluble drugs from spray chilled gelucire 50/13 microspheres.J. Pharm. Sci.201099126227410.1002/jps.2183219653284
     [Google Scholar]
  136. E ElerakyN. M OmarM. A MahmoudH. A Abou-TalebH. E. Eleraky N Nanostructured lipid carriers to mediate brain delivery of Temazepam: design and in vivo study.Pharmaceutics202012545110.3390/pharmaceutics1205045132422903
     [Google Scholar]
  137. PatlollaR.R. ChouguleM. PatelA.R. JacksonT. TataP.N.V. SinghM. Formulation, characterization and pulmonary deposition of nebulized celecoxib encapsulated nanostructured lipid carriers.J. Control. Release2010144223324110.1016/j.jconrel.2010.02.00620153385
     [Google Scholar]
  138. SungJ.C. PulliamB.L. EdwardsD.A. Nanoparticles for drug delivery to the lungs.Trends Biotechnol.2007251256357010.1016/j.tibtech.2007.09.00517997181
     [Google Scholar]
  139. JaquesP.A. KimC.S. Peter A. Jaques, Chong S. Kim Measurement of total lung deposition of inhaled ultrafine particles in healthy men and women.Inhal. Toxicol.200012871573110.1080/0895837005008515610880153
     [Google Scholar]
  140. Patil-GadheA. KyadarkunteA. PatoleM. PokharkarV. Montelukast-loaded nanostructured lipid carriers: Part II Pulmonary drug delivery and in vitro–in vivo aerosol performance.Eur. J. Pharm. Biopharm.201488116917710.1016/j.ejpb.2014.07.00725078860
     [Google Scholar]
  141. GarbuzenkoO.B. KbahN. KuzmovA. PogrebnyakN. PozharovV. MinkoT. Inhalation treatment of cystic fibrosis with lumacaftor and ivacaftor co-delivered by nanostructured lipid carriers.J. Control. Release201929622523110.1016/j.jconrel.2019.01.02530677435
     [Google Scholar]
  142. AbdelkawiA. SlimA. ZinouneZ. PathakY. Surface modification of metallic nanoparticles for targeting drugs.Coatings2023139166010.3390/coatings13091660
     [Google Scholar]
  143. ChoiM. ChoiW.K. JungC.H. KimS.B. The surface modification and characterization of SiO2 nanoparticles for higher foam stability.Sci. Rep.20201011939910.1038/s41598‑020‑76464‑w33173140
     [Google Scholar]
  144. AmmarH.O. GhorabM.M. MostafaD.M. IbrahimE.S. Folic acid loaded lipid nanocarriers with promoted skin antiaging and antioxidant efficacy.J. Drug Deliv. Sci. Technol.201631728210.1016/j.jddst.2015.11.007
     [Google Scholar]
  145. ReinecciusG.A. Liposomes for controlled-release in the food-industry.Encapsulation and Controlled Release of Food IngredientsRisch, S. J., Reineccius, G. A., Eds; ACS Symposium Series 590Washington DC1995590113131
     [Google Scholar]
  146. AcostaE. Bioavailability of nanoparticles in nutrient and nutraceutical delivery.Curr. Opin. Colloid Interface Sci.200914131510.1016/j.cocis.2008.01.002
     [Google Scholar]
  147. EspínJ.C. García-ConesaM.T. Tomás-BarberánF.A. Nutraceuticals: Facts and fiction.Phytochemistry20076822-242986300810.1016/j.phytochem.2007.09.01417976666
     [Google Scholar]
  148. HuangQ. YuH. RuQ. Bioavailability and delivery of nutraceuticals using nanotechnology.J. Food Sci.2010751R50R5710.1111/j.1750‑3841.2009.01457.x20492195
     [Google Scholar]
  149. KatouzianI. Faridi EsfanjaniA. JafariS.M. AkhavanS. Formulation and application of a new generation of lipid nano-carriers for the food bioactive ingredients.Trends Food Sci. Technol.201768142510.1016/j.tifs.2017.07.017
     [Google Scholar]
  150. KoynovaR. WangL. MacDonaldR.C. An intracellular lamellar–nonlamellar phase transition rationalizes the superior performance of some cationic lipid transfection agents.Proc. Natl. Acad. Sci. USA200610339143731437810.1073/pnas.060308510316983097
     [Google Scholar]
  151. GibbsB.F. KermashaS. AlliI. MulliganC.N. Encapsulation in the food industry: A review.Int. J. Food Sci. Nutr.199950321322410.1080/09637489910125610627837
     [Google Scholar]
  152. MohammadiA. JafariS.M. MahoonakA.S. GhorbaniM. Liposomal/nanoliposomal encapsulation of food-relevant enzymes and their application in the food industry.Food Bioprocess Technol.2021141233810.1007/s11947‑020‑02513‑x
     [Google Scholar]
  153. LiuD. LiuZ. WangL. ZhangC. ZhangN. Nanostructured lipid carriers as novel carrier for parenteral delivery of docetaxel.Colloids Surf. B Biointerfaces201185226226910.1016/j.colsurfb.2011.02.03821435845
     [Google Scholar]
  154. ChauhanI. YasirM. VermaM. SinghA.P. Nanostructured lipid carriers: A groundbreaking approach for transdermal drug delivery.Adv. Pharm. Bull.202010215016510.34172/apb.2020.02132373485
     [Google Scholar]
  155. SilviaD.R.a. Acetylated cashew gum biopolymer micro and nanoparticles for drug delivery.BR1020180149962A2.2018
  156. SilviaK.F.F. Water-soluble nanoporous solid foam for controlled drug release in mucous membranes.BR1020170073220A2.2017
  157. Mat JalaluddinNS AsemM HarikrishnaJA Ahmad FuaadAAH Recent progress on nanocarriers for topical- mediated rnai strategies for crop protection-a review.Molecules2023286270010.3390/molecules28062700
     [Google Scholar]
  158. LalR. LandonP.B. MoA. The regents of the university of california, assignee. Nanostructured carriers for guided and targeted on-demand substance delivery. US 201701198912017
  159. GeunK.B. JunP.D. Korea food research institute, assignee. nano-structured lipid carrier comprising α-tocopherol and preparing method thereofKR101777616B2017
  160. IsmailR. QiuhongL. LinanH.L. HassanH.A. YunmeiZ. BasiliM.H. Malaysian Palm Oil Council, assignee. Preparation of nanostructured lipid carriers (NLC) method and products made.CN102283809B2016
  161. LafuenteE.G. LuceaG.G. RincónS.V. NavarroM.P. MorenoO.I. HornesG.A. Praxis biopharma research institute, assignee. Lipid nanoparticles for wound healing.EP2821077A12015
  162. UjangZ. Ab RashidA.H. SubohS.K. AhmadZ. OthmanM.N. DiahM.M. A method for producing nanolipid formulation for skin care and/or repair and a nanolipid formulation of the same.WO2015105407A12015
  163. SachdevaM.S. PatlollaR. Florida agricultural and mechanical university, assignee. Nanoparticle formulations for skin delivery.US8715736B22014
  164. SummerS. HongxiaW. Suzhou nakang biotechnology Co., Ltd., assignee. Coenzyme Q nanostructured lipid carrier and preparation method thereof. CN101658468A2013
  165. JianpingL. JiW. China Pharmaceutical University, assignee. Bionic lovastatin nano-structured lipid carrier and preparation method thereof.CN102935077A2013
  166. PetitJ.L.V. GonzalezR.D. BotelloA.F. Lipotec SA, assignee. Lipid nanoparticle capsules. 2013/0017239A12013
  167. QiangX. XueyangD. Southeast University, assignee. Composite anti-screening agent nanostructured lipid carrier and preparation method thereof.CN102688152A2012
  168. JianD.Y. FuqiangY.H. YuanH. Use of nano structured lipid carrier drug feeding systemCN101129335A2010
  169. BondiM.L. GiammonaG. CraparoE.F. DragoF. Consiglio Nazionale Delle Richerche., assignee. Nanostructured lipid carriers containing riluzole and pharmaceutical formulations containing said particlesEP200707648712009
  170. LiuD. NingR. SongJ. LiL. MinghuiL. ShubinL. Shenyang wanai pride medical technology Co., Ltd. Assignee. Novel nano-lipid carrier for injection embodying paclitaxel series substances and preparation method thereof. CN101366697A200918
  171. PopowskiKD MoattiA ScullG SilkstoneD LutzH López de Juan AbadB GeorgeA BelcherE ZhuD MeiX ChengX CisloM GhodsiA CaiY HuangK LiJ BrownAC GreenbaumA DinhPC ChengK Inhalable dry powder mRNA vaccines based on extracellular vesicles.Matter.2022592960297410.1016/j.matt.2022.06.012
     [Google Scholar]
  172. HashamR. SuhaimiS.H. RosliN.A. AzizR. SarmidiM.R. . A nanostructured lipid carrier encapsulates orthosiphon stamineus extract. MYPI 20163000232018
  173. ZhidongL. RuiH YumeiW. BingZ. JiaweiL. JiaxinP. PanG. DongliQ. NanL. A kind of gambogicacid nano structured lipid carrier and preparation method thereof of cyclic peptide modification.CN1088530542018
  174. WangB. WangQ. BaiL. A kind of polymer thermal sensitive liposome loading yeast dextran and carnosic acid. CN1089044502018
  175. Hong GeunP. GeunP. Ko SangH. SangH. Jo HyeE. HyeE. Kim YeongE. YeongE. Curcumin nanostructured lipid carrier having improved heat stability and efficient stabilization heat treatment method thereofKR10201900243972019
  176. BehlG. KumariS. O'reillyN. O’donovanO. McloughlinP. KentD. FitzhenryL. BehhaenryE. Ocular drug delivery.WO2019123420A12019
  177. XieM. XuM. ChenX. ZhouM. A kind of nano structured lipid carrier and its preparation method and application of synergistic treatment glioma.CN1100134712019
  178. SarmidiM.R. MohamadS.T. HashamR. A nanostructured lipid carrier encapsulates bromelain extract.MYPI 2018300001.2018
  179. PathaniaA. KumarM. SarupP. BhattS. PanduranganA. SainiV. Novel nanostructured lipid carrierbased ophthalmic controlled release formulation for treatment in fungal keratitis. IN2018110212132019
  180. FoxC.B. KhandharA.P. VanH.N. ErasmusJ.G. LinS.S. Nanostructured lipid carriers and stable emulsions and uses thereof.EP36382072020
  181. ThuyVN VanTV DaoAH LeeBJ Nanostructured lipid carriers and their potential applications for versatile drug delivery via oral administration.OpenNano20228100064
     [Google Scholar]
  182. NaghipoorJ. RabczukT. A mechanistic model for drug release from PLGA-based drug eluting stent: A computational study.Comput. Biol. Med.20179090152210.1016/j.compbiomed.2017.09.00128917119
     [Google Scholar]
  183. VersyptAN PackDW BraatzRD Mathematical modeling of drug delivery from autocatalytically degradable PLGA microspheres—A review. J Control Release.201316512937
     [Google Scholar]
  184. ValizadehN RabczukT Isogeometric analysis of hydrodynamics of vesicles using a monolithic phase-field approach. Comput Methods Appl Mech Eng202238811419110.1016/j.cma.2021.114191
     [Google Scholar]
/content/journals/cnanom/10.2174/0124681873283751240206071835
Loading
Nanostructured Lipid Carriers: A Novel Platform in the Formulation of Targeted Drug Delivery Systems
Curr Nanomed 15, 26 (2025); https://doi.org/10.2174/0124681873283751240206071835
/content/journals/cnanom/10.2174/0124681873283751240206071835
/content/journals/cnanom/10.2174/0124681873283751240206071835
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): box behnken design (BBD); central composite design (CCD); design of experiments (DOE); Nanostructured lipid carriers (NLCs); plackett burman design; response surface methodology (RSM)

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test